Literature DB >> 32301034

Our Most Powerful Weapon to Fight COVID-19: Patient Involvement.

Peter J Pitts1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32301034      PMCID: PMC7160609          DOI: 10.1007/s40271-020-00421-y

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


× No keyword cloud information.
The COVID-19 pandemic has catapulted the issue of the patient voice in healthcare and healthcare policy to the front of the global agenda. From social distancing, quarantines, and the wearing of masks, to questions surrounding the urgency of vaccines, hygiene, clinical trials, ‘emergency use authorizations’, testing, and convalescent plasma, the world has moved beyond general issues such as health literacy to a more crucial issue … the role of the patient voice in partnering to save our species from a devastating virus though informed and active participation. Our armamentarium of medical weapons to fight the COVID-19 virus (swifter and more accurate testing, re-purposed existing therapeutics and experimental medicines, expedited vaccine development) have received the most attention, but it is the active participation of patients and (more broadly) the general population that has ‘flattened the curve’. The pandemic has resulted in an evolution of healthcare rhetoric. From a healthcare policy perspective, we have been discussing ‘the patient voice’ in a passive manner. An important lesson from the COVID-19 experience is that we must now shift to a more comprehensive understanding of ‘patient actions’. More important than these actions are the myths and facts that drove them. This raises crucial questions. How can truthful, accurate and non-misleading information be made available to non-medical professionals? From whom should it come? What are the best methods of communication? The circumstances surrounding hydrocloroquine [1, 2] highlight both the power of hope and the dangers of hyperbole. As with any ecosystem, the component parts of our healthcare systems are not necessarily equal to each other, but they are all requirements for success. What the patient voice must fight for is equal respect and a recognition of mutual value. It is not a question of ‘equal’ but of ‘integral’. The global struggle against COVID-19 is World War III and we are all conscripted. Whether you are a physician, nurse, hospital technician, academic researcher, biopharmaceutical executive, police officer, firefighter, teacher, politician, parent, patient, or caregiver, we have a powerful and active role to play. When cities are burning and casualties are mounting, there is no place for casual observers. We must all shoulder our metaphorical rifles and march forward together. All the more reason to elevate a discussion of the twenty-first century patient voice in healthcare [3]. In the words of W. Edwards Deming, “Change is not required. Survival is not mandatory”. We must not pass up these opportunistic teaching moments.
  2 in total

1.  Towards Meaningful Engagement for the Patient Voice.

Authors:  Peter J Pitts
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

2.  Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology.

Authors:  Brian Owens
Journal:  Lancet Rheumatol       Date:  2020-04-01
  2 in total
  4 in total

Review 1.  Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors:  Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal:  Front Pharmacol       Date:  2020-09-11       Impact factor: 5.810

2.  Spiritual Support During COVID-19 in England: A Scoping Study of Online Sources.

Authors:  Irena Papadopoulos; Runa Lazzarino; Steve Wright; Poppy Ellis Logan; Christina Koulouglioti
Journal:  J Relig Health       Date:  2021-04-19

3.  Patient and public involvement in the build-up of COVID-19 testing in Sweden.

Authors:  Mio Fredriksson
Journal:  Health Expect       Date:  2022-03-07       Impact factor: 3.377

4.  Dealing with Discontinuity in Cancer Care Trajectories: Patients' Solutions.

Authors:  Debbie Vermond; Souad El Habhoubi; Esther de Groot; Larike Bronkhorst; Niek de Wit; Dorien Zwart
Journal:  Patient       Date:  2021-06-25       Impact factor: 3.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.